The efficacy and safety of adalimumab in psoriatic arthritis Christopher T. Ritchlin Clinical Trials Report Pages: 329 - 329
The eficacy and safety of alefacept in psoriatic arthritis Christopher T. Ritchlin Clinical Trials Report Pages: 330 - 331
Mechanisms of pathologic new bone formation Kurt de VlamRik JU LoriesFrank P. Luyten OriginalPaper Pages: 332 - 337
Dactylitis: Pathogenesis and clinical considerations Paul J. HealyPhilip S. Helliwell OriginalPaper Pages: 338 - 341
Animal models of psoriasis and psoriatic arthritis: An update Curdin ConradFrank O. Nestle OriginalPaper Pages: 342 - 347
Management of psoriatic arthritis: The therapeutic interface between rheumatology and dermatology Philip Mease OriginalPaper Pages: 348 - 354
Metabolic disorders in patients with psoriasis and psoriatic arthritis Lotus MallbrisChristopher T. RitchlinMona Ståhle OriginalPaper Pages: 355 - 363
Efficacy of costimulation blockade with abatacept in rheumatoid arthritis patients refractory to tumor necrosis factor-α inhibition Larry Moreland Clinicals Trials Report Pages: 367 - 367
Efficacy and safety of rituximab in rheumatoid arthritis patients refractory to methotrexate Larry Moreland Clinicals Trials Report Pages: 368 - 368
Genetic markers of treatment response in rheumatoid arthritis Joanna WesolyJudith A. M. WesselsTom W. J. Huizinga OriginalPaper Pages: 369 - 377
Ultrasonography and magnetic resonance imaging in early rheumatoid arthritis: Recent advances Mikkel ØstergaardUffe M. DØhnFiona M. McQueen OriginalPaper Pages: 378 - 385
Gene therapy works in animal models of rheumatoid arthritis so what! Fons A. J. van de LooJeroen GeurtsWim B. van den Berg OriginalPaper Pages: 386 - 393
Recent advances in the genetics of rheumatoid arthritis Chris DeightonLindsey A. Criswell OriginalPaper Pages: 394 - 400